AVXL
Anavex Life Sciences Corp
2.40$
+1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -52.9% | +22.1% | -7.7% | +66.8% | -29.8% | +20.4% | -7.6% | +47.0% | +29.6% | +6.4% | -5.3% | -18.2% | +34.8% | -4.7% | +11.1% | -9.2% | +29.8% | -15.2% | +33.4% | +4.6% | -7.6% | -0.6% | +7.8% | +22.7% | +6.0% | -12.5% | -2.6% | -2.2% | -13.7% | +12.0% | +21.4% | -2.2% | -9.6% | -5.3% | +0.7% | -26.8% | -36.2% | -10.0% | -1.1% | – | |
| – | -49.8% | -0.9% | +25.9% | -3.1% | +2.7% | +6.6% | +8.8% | -8.6% | +18.9% | +17.0% | -32.6% | +17.8% | -17.3% | +27.2% | -19.7% | +1.6% | +4.8% | +51.9% | +9.0% | +18.3% | +6.5% | -4.9% | +9.3% | +22.5% | -15.0% | -13.1% | +12.7% | -20.2% | +4.0% | +7.5% | -3.6% | -0.4% | +13.1% | -16.7% | +71.7% | -21.1% | -40.1% | +7.8% | +4.1% | – | |
| – | -52.2% | +14.6% | +1.2% | +42.4% | -21.0% | +15.7% | -4.0% | +28.0% | +27.3% | +9.0% | -12.3% | -11.3% | +21.6% | +1.0% | +5.3% | -7.4% | +25.2% | -4.8% | +27.0% | +7.9% | -4.3% | -1.7% | +8.2% | +22.7% | +0.5% | -7.6% | -4.6% | -6.5% | -10.1% | +11.0% | +15.7% | -1.8% | -5.2% | -7.9% | +15.6% | -25.0% | -37.5% | -4.4% | +0.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2,386.4% | +396.5% | +47.0% | +48.5% | -23.3% | -5.7% | +8.0% | +0.0% | +154.7% | -34.7% | -32.3% | +333.8% | -69.1% | +50.2% | -20.1% | -87.6% | -77.7% | +491.1% | +24.3% | -37.6% | -31.3% | +54.3% | +2,934.0% | +206.5% | +79.9% | -24.0% | +89.6% | -38.1% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +416.8% | -69.1% | +2.9% | -7.6% | +3.0% | +196.2% | -391.7% | – | -75.4% | +451.2% | -59.8% | -68.3% | +50.7% | -861.7% | – | +79.2% | +586.7% | -54.5% | +44.5% | +264.9% | -78.9% | -0.6% | +196.7% | +137.8% | -109.5% | – | -18.0% | -256.0% | – | +23.5% | -163.8% | – | – | – | – | – | – | -250.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.